Abstract
To study the effectiveness and nephrotoxic sideeffects of cydosporin A (CsA) in renal transplant recipients, a prospective randomised trial was designed to compare CsA with azathioprine (Aza). Each treatment group consisted of 40 patients; in the CsA group, 18 were randomly selected for conversion to Aza after 3 months. The 1-year graft survival for CsA-treated patients was 87% compared with 66% for the Aza group (P=0.033). Anti-rejection therapy was administrated to 78% of the patients in the Aza group and 47% of those in the CsA group (P
Original language | English (US) |
---|---|
Pages (from-to) | 44-49 |
Number of pages | 6 |
Journal | Nephrology Dialysis Transplantation |
Volume | 1 |
Issue number | 1 |
DOIs | |
State | Published - 1986 |
Externally published | Yes |
Keywords
- Cydosporin
- Hypertension
- Nephrotoxicity
- Proteinuria
- Renal transplantation
ASJC Scopus subject areas
- Nephrology
- Transplantation